Literature DB >> 9249982

New anti-HIV-1, antimalarial, and antifungal compounds from Terminalia bellerica.

R Valsaraj1, P Pushpangadan, U W Smitt, A Adsersen, S B Christensen, A Sittie, U Nyman, C Nielsen, C E Olsen.   

Abstract

A bioactivity-guided fractionation of an extract of Terminalia bellerica fruit rind led to the isolation of two new lignans named termilignan (1) and thannilignan (2), together with 7-hydroxy-3',4'-(methylenedioxy)flavan (3) and anolignan B (4). All four compounds possessed demonstrable anti-HIV-1, antimalarial, and antifungal activity in vitro.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9249982     DOI： 10.1021/np970010m

Source DB:  PubMed          Journal:  J Nat Prod        ISSN： 0163-3864            Impact factor:   4.050


  23 in total

1.  Antiplasmodial activity of botanical extracts against Plasmodium falciparum.

Authors:  Asokan Bagavan; Abdul Abdul Rahuman; Chinnaperumal Kamaraj; Naveen Kumar Kaushik; Dinesh Mohanakrishnan; Dinkar Sahal
Journal:  Parasitol Res       Date:  2010-11-16       Impact factor: 2.289

2.  Antiproliferative xanthones of Terminalia calcicola from the Madagascar rain forest.

Authors:  Shugeng Cao; Peggy J Brodie; James S Miller; Richard Randrianaivo; Fidy Ratovoson; Chris Birkinshaw; Rabodo Andriantsiferana; Vincent E Rasamison; David G I Kingston
Journal:  J Nat Prod       Date:  2007-02-27       Impact factor: 4.050

3.  Saponins and a lignan derivative of Terminalia tropophylla from the Madagascar Dry Forest.

Authors:  Shugeng Cao; Peggy J Brodie; Martin Callmander; Richard Randrianaivo; Etienne Rakotobe; Vincent E Rasamison; David G I Kingston
Journal:  Phytochemistry       Date:  2009-10-28       Impact factor: 4.072

4.  Preventive effect of Terminalia bellirica on obesity and metabolic disorders in spontaneously obese type 2 diabetic model mice.

Authors:  Hiroko Makihara; Tsutomu Shimada; Eriko Machida; Masatomi Oota; Rika Nagamine; Masahito Tsubata; Kaoru Kinoshita; Kunio Takahashi; Masaki Aburada
Journal:  J Nat Med       Date:  2011-11-22       Impact factor: 2.343

5.  Alteration of Bax/Bcl-2 ratio contributes to Terminalia belerica-induced apoptosis in human lung and breast carcinoma.

Authors:  Nikhil Baban Ghate; Bibhabasu Hazra; Rhitajit Sarkar; Dipankar Chaudhuri; Nripendranath Mandal
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-01-08       Impact factor: 2.416

6.  Evaluation of antibacterial activity, phytochemical constituents, and cytotoxicity effects of Thai household ancient remedies.

Authors:  Sasitorn Chusri; Naruephan Sinvaraphan; Ploypailin Chaipak; Atita Luxsananuwong; Supayang Piyawan Voravuthikunchai
Journal:  J Altern Complement Med       Date:  2014-12       Impact factor: 2.579

7.  Synergistic growth inhibitory effects of Phyllanthus emblica and Terminalia bellerica extracts with conventional cytotoxic agents: doxorubicin and cisplatin against human hepatocellular carcinoma and lung cancer cells.

Authors:  Khosit Pinmai; Sriharut Chunlaratthanabhorn; Chatri Ngamkitidechakul; Noppamas Soonthornchareon; Chariya Hahnvajanawong
Journal:  World J Gastroenterol       Date:  2008-03-14       Impact factor: 5.742

8.  Acute and chronic toxicity studies of the water extract from dried fruits of Terminalia bellerica (Gaertn.) Roxb. In Spargue-Dawley rats.

Authors:  Seewaboon Sireeratawong; Kanjana Jaijoy; Watcharin Panunto; Urarat Nanna; Nirush Lertprasertsuke; Noppamas Soonthornchareonnon
Journal:  Afr J Tradit Complement Altern Med       Date:  2012-12-31

9.  A new glycosidic flavonoid from Jwarhar mahakashay (antipyretic) Ayurvedic preparation.

Authors:  Mradu Gupta; B P Shaw; A Mukherjee
Journal:  Int J Ayurveda Res       Date:  2010-04

10.  Clinical evaluation of the efficacy of Dashanga Kwatha Ghana Vati in the management of Urdhwaga Amlapitta (Non-ulcer dyspepsia).

Authors:  Umapati C Baragi; Mahesh K Vyas
Journal:  Ayu       Date:  2012-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.